OTIRELAKS

Active material: Lidokain, Fenazon
When ATH: S02DA30
CCF: Preparation with anti-inflammatory and mestnoanestezirutm effect for local application in ENT practice
ICD-10 codes (testimony): H60, H66
At KFU: 05.01.03.02
Manufacturer: S.C. ROMPHARM Company S.R.L. (Romania)

Pharmaceutical form, composition and packaging

Ear Drops as a clear, colorless or slightly yellowish solution.

Excipients: Sodium Thiosulphate pentahydrate, ethanol 96%, glycerol, Sodium hydroxide (solution 1 m), Purified water.

15 ml (17.1 g) – dropper bottle plastic (1) – packs cardboard.

Pharmacological action

Combination preparation for topical application. Provides mestnoanestezirutee and anti-inflammatory effect.

Fenazon – analgesic-antipyretic and analgesic with anti-inflammatory activity. Lidokain – mestnый anesthetic. The combination of Phenazone and lidocaine promotes more rapid onset of anaesthesia, as well as increases its intensity and duration.

Pharmacokinetics

The active substances are not absorbed into the bloodstream when an intact eardrum.

Testimony

Local symptomatic treatment and pain relief in adults and children (including newborns) at:

-external otitis;

— in the treatment of otitis media with intact the eardrum;

— barotravmatičeskom otite.

Dosage regimen

Drops of fluid in the ear canal for 3-4 drops 2-3 times / day. Avoid contact of cold solution with auricle bottle before use, warm in your hands.

The course of treatment should not exceed 10 d.

Side effect

Maybe: Local allergic reactions, irritation and hyperemia meatus, slight pain at the time of application.

Contraindications

-perforation of tympanic membrane;

- Hypersensitivity to the drug;

-hypersensitivity to derived pirazolona.

Pregnancy and lactation

Pregnancy may only, when the intended benefits to the mother outweighs the potential risk to the fetus.

If necessary, use during lactation should decide the issue of termination of breastfeeding.

Cautions

You must verify the integrity of the tympanic membrane before applying the product. In the case of drugs in a perforated eardrum, active substances can penetrate the bloodstream, that can lead to complications.

The duration of not more than Otirelaksa 10 days, then hold the assigned therapy correction.

If you are using the drug in combination with other Otirelaks ear drops must maintain a minimum interval 30 min between zakapyvaniâmi.

It will be appreciated, the drug contains an active component, who can give a positive test in a doping control.

Overdose

The drug overdose Otirelaks not available.

Drug Interactions

Currently, information about drug interactions with other drugs Otirelaks are missing.

Conditions of supply of pharmacies

The drug is released under the prescription.

Conditions and terms

The drug should be stored in a dry, protected from light, inaccessible to children at temperature not exceeding 25 ° C. Shelf life – 3 year.

After opening the bottle the drug should be used within 6 months.